News

Obesity Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
DelveInsight’s Obesity pipeline report depicts a robust space with 80+ active players working to develop 100+ pipeline ...
The Meadville Tribune4d
Ozempic ingredient linked to reduced dementia risk in diabetes patients, CWRU study shows
The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...
Managed Healthcare Executive1d
J&J Submits NDA for Icotrokinra, a New Type of Therapy for Plaque Psoriasis
Icotrokinra is a first-in-class targeted oral peptide that blocks interleukin (IL) 23 and its receptor, which plays a key ...
Can Ozempic and other GLP-1 drugs be substitute for work outs? Dr Ambrish Mithal and Raj Ganpath discuss
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
Ozempic Could Change Births in America
Newsweek spoke to some experts about whether the weight loss drug could have an impact on birth rates in America.
The Chosun Ilbo on MSN1d
S. Korean companies join global race for obesity drugs
As the global obesity medication market skyrockets, South Korean pharmaceuticals are rushing to develop national obesity ...
Eli Lilly: Competition Melts Away
Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...
Obstructive Sleep Apnea Clinical Trial Pipeline Expands As 12+ Companies Driving Innovation In OSA Therapeutics Delveinsight
The obstructive sleep apnea (OSA) market is being propelled by the rapid evolution of early detection and diagnostic tools. Technologies like home sl ...